Laval, Canada

Normand Blais

This inventor holds 21 USPTO granted patents and 6 published patent applications, plus 15 CIPO patents and 13 EPO patents, primarily in Vaccine Development. Top assignees: Glaxosmithkline Biologicals Sa, Glaxo Group Limited, Glaxosmithkline LLC. Active years: 2012-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Normand Blais. Retrieved from https://idiyas.com/inventor/normand-blais

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 21 

% Patents Active = 81.0

 

 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 112(Granted Patents)


Location History:

  • Lava, CA (2013)
  • Laval, CA (2012 - 2021)

Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Fusion Proteins
Combination Vaccines
UspA2 Proteins
Recombinant RSV Vaccines
Immunogenic Composition
MAGE Antigens
Modified Antigens
Expression Systems
CASB7439 Constructs
Pilin A
Haemophilus Influenzae
Tuberculosis Antigens
21 patents (USPTO):Explore Patents

Title: Normand Blais: Leading the Way in Innovation

Introduction:

Normand Blais, a visionary inventor hailing from Laval, Canada, is spearheading a revolution in the realms of healthcare and biotechnology. With 21 patents to his name and a relentless drive for progress, Blais is making waves in the industry with his groundbreaking innovations.

Latest Patents:

Blais's latest patents include the development of Fusion Proteins and Combination Vaccines comprising Protein E and Pilin A. These patents focus on treating chronic hepatitis B infection in humans by leveraging innovative methods and composition comprising UspA2 protein constructs.

Career Highlights:

Having worked with reputable companies like GlaxoSmithKline Biologicals SA and Glaxo Group Limited, Blais has honed his skills and expertise in the field of biotechnology. His contributions have not only advanced scientific research but have also paved the way for novel treatment modalities in chronic diseases.

Collaborations:

Throughout his career, Blais has collaborated with esteemed professionals in the field, including his coworkers Steve Labbe and Jan Poolman. Their joint efforts have resulted in pioneering research and the development of cutting-edge technologies that have the potential to revolutionize the healthcare industry.

Conclusion:

Normand Blais stands as a beacon of innovation, pushing the boundaries of what is possible in the field of biotechnology. His passion for creating a better future through inventive solutions continues to leave a lasting impact on the world, shaping the landscape of healthcare and inspiring future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…